The SLC26A1 gene helps move sulfate and other small charged particles in the kidneys, liver, and gut, which supports your body’s chemical balance. This gene plays an important role in keeping sulfate levels steady and limiting buildup of compounds that can form crystals. If it does not work properly, some people may develop low sulfate levels and be more likely to form kidney or bladder stones, especially calcium oxalate stones. SLC26A1 is not a gene that commonly appears in public awareness or media stories.
What is a gene?
A gene is a section of DNA that holds instructions your cells use to make molecules or regulate processes in the body. Some genes carry the instructions for producing proteins, the parts of cells that do much of the work. Others mainly help regulate when certain processes happen, where they happen, and how strongly they occur. Together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medicines. To explore this topic in greater depth, you can find more in the LearnHub.
Overview
SLC26A1Gene function
What if the gene works
The SLC26A1 gene helps move sulfate and other charged particles across cell membranes, especially in the kidneys, liver, and intestine. This supports normal sulfate balance and helps the body handle waste products such as oxalate.
Risk
What if the gene does not work
Variants in the SLC26A1 gene are linked to recurrent kidney and urinary stones, especially calcium oxalate stones. Effects may range from milder stone risk to earlier or more frequent stones with more severe variants.
Treatment
What does that mean for your treatment
No treatment or management approach specific to the SLC26A1 gene is currently established in clinical guidelines. Research is exploring whether SLC26A1 variants may help explain some cases of recurrent kidney stones by altering sulfate and oxalate handling, but this has not yet led to gene-directed drug choices.
Gene function
What if the gene works
The SLC26A1 gene helps move key charged particles across cell membranes, especially sulfate. This transport supports the body’s chemical balance and keeps sulfate available for normal day to day cell work. It is part of the steady transport system that helps tissues handle routine molecules efficiently.
The SLC26A1 gene helps cells move sulfate across their outer membrane. Sulfate is used in many routine chemical jobs that support steady cell activity.
Its protein swaps sulfate and other small charged particles, such as bicarbonate and oxalate, across the cell membrane. This steady exchange helps cells manage everyday chemical traffic.
By moving these particles, the SLC26A1 gene supports stable salt and acid base balance in body fluids. This helps tissues keep everyday chemistry within a healthy range.
A reliable sulfate supply supports sulfation (a common chemical tagging step) used throughout the body. Understanding what the SLC26A1 gene does in the body helps explain how cells carry out many routine metabolic tasks.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some situations, however, a variant can change how a gene functions more clearly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the SLC26A1 gene change the shape or stability of its transporter protein, so less of it reaches the cell surface or it moves sulfate and related charged particles less effectively. Some milder variants partly reduce transport, while more severe variants can leave the protein largely inactive or absent. This explains how SLC26A1 gene variants affect sulfate transport in cells and, in some cases, oxalate exchange as well.
How variants are linked to conditions
Pathogenic variants in the SLC26A1 gene can cause a rare inherited tendency to develop recurrent calcium oxalate kidney stones, also called nephrolithiasis or urolithiasis. In people with harmful variants in both copies of the gene, this result can confirm an SLC26A1 related kidney stone condition. Research is still defining how often different variants in the SLC26A1 gene linked to kidney stones lead to symptoms.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are widespread across the general population. Most do not directly affect health and simply reflect natural variation among people. For many genes, having a variant associated with a condition points to a possible link rather than a confirmed diagnosis, particularly when several genes and environmental influences also play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that clearly increase or reduce risk related to the SLC26A1 gene. If a disease-causing change is present, day-to-day risk can still vary from one person to another, so personal guidance from a doctor or genetic counselor can help put family history and symptoms into context.
Inheritance of SLC26A1 variants
SLC26A1-related conditions are inherited in an autosomal recessive pattern. This means a person usually needs to inherit two disease-causing variants in the SLC26A1 gene, one from each parent, to be affected. For families asking how SLC26A1 is inherited, parents who each carry one variant typically have a 25% chance with each pregnancy of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child who inherits neither variant. This pattern is the same for sons and daughters.
What does my SLC26A1 result mean for my family?
For families with a disease-causing change in the SLC26A1 gene, the condition is passed down in a recessive pattern. This usually means siblings may also have the condition or be carriers, and parents are often healthy carriers themselves. Other relatives may also be carriers, especially on the same side of the family. What this means for relatives depends on the exact result found in your family.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the SLC26A1 gene, genetic testing for SLC26A1 variants usually analyzes DNA from a blood or saliva sample. A lab reads the gene’s code, looks for variants, and reports whether a finding is known to be linked with health effects, uncertain, or not currently considered clinically significant.
When should I consider getting a genetic test?
There is not yet a broadly established reason to test the SLC26A1 gene on its own. Testing may be considered as part of a wider genetic check for people with repeated kidney stones or a strong family history of stone disease, guided by a doctor or genetic counselor.
A genetic result is only one part of your health story
Genetic results can provide meaningful insight, but how much they show depends on the condition and the kind of variant involved. The way the body works over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, transports, or reacts to a drug, so the same treatment may work better for one person than another. This is common and can influence both how well a medicine helps and how likely someone is to notice side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the way a person responds to medication. It looks at the relationship between genes and drugs to help explain why the same treatment can work differently in different people. For many medicines, genes influence how strongly a drug works or how the body handles it. Understanding this can support more informed, individualized treatment decisions. More information about this topic is available in the LearnHub.
Drugs influenced by the SLC26A1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice, so general questions about medicines, side effects, or new symptoms are best discussed with your doctor. Research on the SLC26A1 gene has mostly focused on how the body moves certain salts and chemicals linked with kidney stones, rather than on a proven effect on drug response used in routine care.